Yes, virtually every standard drug test screens for marijuana. It is one of five substance categories on the federal workplace drug panel, alongside cocaine, amphetamines, opioids, and PCP. Whether you’re being tested for a new job, a Department of Transportation role, or a court-ordered screening, marijuana is almost certainly on the list.
What the Test Actually Detects
Drug tests don’t look for THC itself, the compound that produces marijuana’s psychoactive effects. Instead, urine tests target a byproduct your body creates when it breaks THC down. This metabolite enters your bloodstream within minutes of smoking and lingers in your system far longer than THC does. Active THC in your blood typically drops to very low levels within four to six hours, but the metabolite can show up in urine for days or weeks afterward.
This is an important distinction: a positive urine test only confirms that you used marijuana at some point in the recent past. It does not indicate that you were impaired at the time the sample was collected, and there’s no reliable way to work backward from a urine result to determine exactly when you last used or how much.
How Long Weed Stays Detectable
Detection windows vary dramatically depending on how often you use marijuana. For someone who smokes once, the metabolite typically peaks in urine 10 to 18 hours later and stays above detectable levels for roughly 80 to 100 hours, or about three to four days. For a casual user, detection is possible for up to two weeks.
Chronic, daily users face a much longer window. Studies have found positive results persisting for 30 days under lab-grade testing, and in some cases up to 67 or even 93 days using the standard screening cutoff. This extended window exists because THC is fat-soluble. It accumulates in fatty tissue over time and releases slowly back into the bloodstream, meaning your body can keep producing detectable metabolites long after you stop using.
Individual factors like metabolism, body fat percentage, hydration, exercise habits, and age all influence how quickly you clear the metabolite. Two people who smoke the same amount can test positive for very different lengths of time.
Types of Tests and Their Windows
Urine testing is the most common method for workplace screening. It uses a two-step process: an initial immunoassay screen with a cutoff of 50 ng/mL, followed by a more precise confirmation test with a cutoff of 15 ng/mL. If the initial screen flags positive but the confirmation test comes in below 15 ng/mL, the result is reported as negative. This two-tier system exists to reduce false positives.
Hair testing offers the longest detection window. A standard 1.5-inch hair sample covers approximately 90 days of drug use history. Employers sometimes prefer hair testing because it captures a broader timeline and is harder to cheat. Oral fluid (saliva) testing, by contrast, has a much shorter window, generally detecting use within roughly the last one to two days. Blood tests are similarly short-lived and primarily used in situations like roadside impairment checks, where recent use matters more than past exposure.
Can Secondhand Smoke Cause a Positive Result
Under normal conditions, no. Researchers at Johns Hopkins tested this by seating nonsmokers in a sealed, unventilated room alongside active marijuana smokers for extended sessions. At the standard 50 ng/mL screening cutoff, only a single nonsmoker out of dozens of specimens produced a positive result, a rate of 0.4%. When the room had normal ventilation comparable to home air conditioning, not a single nonsmoker tested positive even at the more sensitive 20 ng/mL cutoff.
In other words, you’d need to be trapped in an unventilated, smoke-filled room for a sustained period to have any realistic chance of a positive test. Casual exposure at a party or walking past someone smoking outdoors is extremely unlikely to trigger a result.
CBD Products and Unexpected Positives
Pure CBD does not cause a positive marijuana test. But most CBD products aren’t pure CBD. Full-spectrum hemp extracts legally contain up to 0.3% THC, and that small amount can add up with regular use. In one clinical trial, participants took a retail hemp-derived CBD extract three times daily for four weeks. Nearly half of them produced urine samples that exceeded the federal confirmation cutoff of 15 ng/mL.
Vaporized CBD-dominant cannabis products pose a similar risk. In a study using a product with 10.5% CBD and just 0.39% THC (barely above the legal hemp limit), some participants tested positive at the standard 50 ng/mL screening cutoff after a single session. If you’re subject to drug testing, even legal hemp-derived CBD products carry a real risk of triggering a marijuana-positive result, particularly with daily use or higher doses.
What Can Cause a False Positive
Several common medications can cross-react with the initial immunoassay screen, producing a result that looks like marijuana. Known culprits include ibuprofen, naproxen, the anti-nausea medication promethazine, and even some baby wash products. The HIV medication efavirenz and high-dose riboflavin (vitamin B2) have also been flagged.
This is one reason the confirmation test exists. The second-stage analysis uses a different technology that can distinguish the actual marijuana metabolite from these look-alikes. If you’re taking any of these medications and receive a preliminary positive, the confirmation step should clear it up. Letting the testing facility know about your medications beforehand can also help avoid confusion.
How Labs Catch Tampering
If you’re thinking about diluting your sample by drinking excessive water, labs are looking for that. Federal testing guidelines require labs to measure the creatinine concentration and pH of every specimen. If creatinine is unusually low (a sign of heavy dilution), the lab must also check the sample’s specific gravity. Specimens are additionally screened for oxidizing adulterants, which are chemicals found in some products marketed as “detox” drinks or sample additives.
A sample flagged as dilute may require a retest. A sample identified as substituted or adulterated is treated as a refusal to test, which in many employment contexts carries the same consequences as a positive result.